Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kim HK"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 22
Tytuł:
Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology-Based EGFR Mutation Assay in Patients with Operable Non-Small Cell Lung Cancer.
Autorzy:
Park IH; GENECAST, Seoul, Korea.
Son DS; Division of Data Science, Data Science Convergence Research Center, Hallym University, Chuncheon, Korea.
Choi YL; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi JH; GENECAST, Seoul, Korea.
Park JE; GENECAST, Seoul, Korea.
Jeon YJ; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho M; Division of Data Science, Data Science Convergence Research Center, Hallym University, Chuncheon, Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kang JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Park S; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim SH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee BC; GENECAST, Seoul, Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 81-91. Date of Electronic Publication: 2023 Jun 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Lung Neoplasms*/diagnosis
Humans ; Alleles ; Prospective Studies ; ErbB Receptors/genetics ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry.
Autorzy:
Yun J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Hong TH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Yang K; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Corporate Authors:
Korean Association for Lung Cancer
Korea Central Cancer Registry
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Oct; Vol. 55 (4), pp. 1171-1180. Date of Electronic Publication: 2023 Apr 17.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/radiotherapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/radiotherapy
Lung Neoplasms*/surgery
Radiosurgery*/adverse effects
Humans ; Retrospective Studies ; Neoplasm Staging ; Registries ; Lung/pathology ; Republic of Korea/epidemiology ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Five-Year Overall Survival and Prognostic Factors in Patients with Lung Cancer: Results from the Korean Association of Lung Cancer Registry (KALC-R) 2015.
Autorzy:
Jeon DS; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim HC; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim SH; Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim TJ; Department of Hospital Pathology, Yeouido St. Mary's hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Moon MH; Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Beck KS; Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Suh YG; Proton Therapy Center, Research Institute and Hospital, National Cancer Center, Goyang, Korea.
Song C; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Ahn JS; Department of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee JE; Division of Pulmonology, Chungnam National University College of Medicine, Daejeon, Korea.
Lim JU; Division of Pulmonary, Allergy and Critical Care Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Jeon JH; Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Jung KW; Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea.
Jung CY; Department of Pulmonary, Daegu Catholic University Medical Center, Daegu Catholic University School of Medicine, Daegu, Korea.
Cho JS; Department of Thoracic and Cardiovascular Surgery, Pusan National University Hospital, Busan, Korea.
Choi YD; Department of Pathology, Chonnam National University Medical School, Gwangju, Korea.
Hwang SS; Department of Public Health Science, Graduate School of Public Healthy, Seoul National University, Seoul, Korea.
Choi CM; Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Pokaż więcej
Corporate Authors:
Korean Association for Lung Cancer
Korea Central Cancer Registry
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Jan; Vol. 55 (1), pp. 103-111. Date of Electronic Publication: 2022 Jun 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/genetics
Small Cell Lung Carcinoma*/epidemiology
Small Cell Lung Carcinoma*/therapy
Humans ; Mutation ; Prognosis ; Registries ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Psychometric Validation of the Korean Version of the Cancer Survivors' Unmet Needs (CaSUN) Scale among Korean Non-Small Cell Lung Cancer Survivors.
Autorzy:
Kang D; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.; Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
Lee G; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, Korea.
Kim S; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.; Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
Nam H; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.; Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.
Kong S; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, Korea.
Shim S; Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea.
Lee JK; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, Korea.
Jung W; Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shin S; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shin DW; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.; Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea.; Department of Family Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho J; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, Korea.; Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea.; Department of Digital Health, SAIHST, Sungkyunkwan University, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2023 Jan; Vol. 55 (1), pp. 61-72. Date of Electronic Publication: 2022 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Cancer Survivors*
Carcinoma, Non-Small-Cell Lung*/therapy
Lung Neoplasms*/diagnosis
Lung Neoplasms*/therapy
Humans ; Male ; Female ; Psychometrics ; Reproducibility of Results ; Survivors ; Surveys and Questionnaires ; Republic of Korea
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Longitudinal changes in pulmonary function and patient-reported outcomes after lung cancer surgery.
Autorzy:
Shin S; Department of Thoracic and Cardiovascular Surgery, School of Medicine, Ewha Womans University, Seoul, South Korea.; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea.
Kong S; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, South Korea.
Kang D; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.; Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea.
Lee G; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, South Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea.; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, South Korea.
Cho J; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea.; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, South Korea.; Center for Clinical Epidemiology, Samsung Medical Center, Seoul, South Korea.; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea. hkts.kim@samsung.com.; Department of Clinical Research Design and Evaluation, SAIHST, Sungkyunkwan University, Seoul, South Korea. hkts.kim@samsung.com.; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, South Korea. hkts.kim@samsung.com.
Park HY; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, South Korea. .; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, South Korea. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2022 Aug 30; Vol. 23 (1), pp. 224. Date of Electronic Publication: 2022 Aug 30.
Typ publikacji:
Evaluation Study; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/surgery
Pulmonary Disease, Chronic Obstructive*/diagnosis
Dyspnea/diagnosis ; Dyspnea/etiology ; Dyspnea/surgery ; Forced Expiratory Volume ; Humans ; Lung/surgery ; Patient Reported Outcome Measures ; Prospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical outcomes of hyperprogression based on volumetry in non-small cell lung cancer after immune checkpoint inhibitor treatment.
Autorzy:
Kim J; Division of Pulmonology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, South Korea.
Kim T; Department of Internal Medicine, The Armed Forces Goyang Hospital, Goyang-si, South Korea.
Jang TW; Division of Pulmonology, Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, South Korea.
Kang H; Department of Radiology, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, South Korea.
Kim MH; Division of Pulmonology, Department of Internal Medicine, Pusan National University Hospital, Pusan, South Korea.
Yoon SH; Division of Pulmonology, Department of Internal Medicine, Pusan National University Yangsan Hospital, Yangsan, South Korea.
Son CH; Division of Pulmonology, Department of Internal Medicine, Gwanghye General Hospital, Pusan, South Korea.
Lee HK; Division of Pulmonology, Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, South Korea.
Kim HK; Division of Pulmonology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Busan, South Korea.
Lee SY; Division of Pulmonology, Department of Internal Medicine, Kyungpook National University Chilgok Hospital, Daegu, South Korea.
Shin KC; Division of Pulmonology, Department of Internal Medicine, Yeungnam University Hospital, Daegu, South Korea.
Han JY; Department of Radiology, Inje University Busan Paik Hospital, Busan, South Korea.
Kang EJ; Department of Radiology, Dong-A University College of Medicine, Busan, South Korea.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Aug; Vol. 13 (15), pp. 2170-2179. Date of Electronic Publication: 2022 Jul 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Disease Progression ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Usefulness of Pulmonary Rehabilitation in Non-Small Cell Lung Cancer Patients Based on Pulmonary Function Tests and Muscle Analysis Using Computed Tomography Images.
Autorzy:
Choi J; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Yang Z; Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Lee J; Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Lee JH; Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Yong HS; Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Lee SY; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2022 Jul; Vol. 54 (3), pp. 793-802. Date of Electronic Publication: 2021 Oct 20.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Humans ; Lung/diagnostic imaging ; Muscles ; Respiratory Function Tests ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Video-assisted thoracoscopic lobectomy versus open lobectomy in the treatment of large lung cancer: propensity-score matched analysis.
Autorzy:
Yun J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea.
Lee J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea.
Shin S; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06531, South Korea. .
Pokaż więcej
Źródło:
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2022 Jan 08; Vol. 17 (1), pp. 2. Date of Electronic Publication: 2022 Jan 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/surgery
Humans ; Pneumonectomy ; Propensity Score ; Retrospective Studies ; Thoracic Surgery, Video-Assisted ; Thoracotomy ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Conditional Survival of Surgically Treated Patients with Lung Cancer: A Comprehensive Analyses of Overall, Recurrence-free, and Relative Survival.
Autorzy:
Shin DW; Department of Family Medicine, Supportive Care Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.; Department of Clinical Research Design and Evaluation and, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.; Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Yoo JE; Healthcare system Gangnan Center, Seoul National University Hospital, Seoul, Korea.
Cho J; Department of Clinical Research Design and Evaluation and, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.; Cancer Education Center, Samsung Medical Center, Seoul, Korea.; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.; Departments of Health, Behavior, and Society and Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Yoon DW; Department of Thoracic and Cardiovascular Surgery, Armed Forces Capital Hospital, Seongnam, Korea.
Lee G; Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.
Shin S; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2021 Oct; Vol. 53 (4), pp. 1057-1071. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung/*mortality
Carcinoma, Non-Small-Cell Lung/*mortality
Carcinoma, Squamous Cell/*mortality
Lung Neoplasms/*mortality
Neoplasm Recurrence, Local/*mortality
Pneumonectomy/*mortality
Adenocarcinoma of Lung/pathology ; Adenocarcinoma of Lung/surgery ; Adult ; Aged ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/surgery ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/surgery ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/pathology ; Lung Neoplasms/surgery ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/surgery ; Prognosis ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effect of perioperative bronchodilator therapy on postoperative pulmonary function among lung cancer patients with COPD.
Autorzy:
Shin SH; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Shin S; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Im Y; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Lee G; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, Republic of Korea.
Jeong BH; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Lee K; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Um SW; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Kim H; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Kwon OJ; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cho J; Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, 81 Irwon-ro, Gangnam-Gu, Seoul, 06351, Republic of Korea.
Kang D; Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, 81 Irwon-ro, Gangnam-Gu, Seoul, 06351, Republic of Korea. .
Park HY; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 06351, Republic of Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 16; Vol. 11 (1), pp. 8359. Date of Electronic Publication: 2021 Apr 16.
Typ publikacji:
Journal Article
MeSH Terms:
Forced Expiratory Volume*
Bronchodilator Agents/*administration & dosage
Carcinoma, Non-Small-Cell Lung/*physiopathology
Carcinoma, Non-Small-Cell Lung/*surgery
Lung Neoplasms/*physiopathology
Lung Neoplasms/*surgery
Perioperative Care/*methods
Pulmonary Disease, Chronic Obstructive/*drug therapy
Pulmonary Disease, Chronic Obstructive/*physiopathology
Aged ; Carcinoma, Non-Small-Cell Lung/etiology ; Female ; Humans ; Lung Neoplasms/etiology ; Male ; Middle Aged ; Postoperative Complications/epidemiology ; Pulmonary Disease, Chronic Obstructive/complications ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
PDX models of human lung squamous cell carcinoma: consideration of factors in preclinical and co-clinical applications.
Autorzy:
Jung HY; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim TH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee JE; DNA Link, Inc, Seoul, South Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Shin S; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee SH; Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Rhee H; DNA Link, Inc, Seoul, South Korea.
Lee HK; DNA Link, Inc, Seoul, South Korea.
Choi HJ; DNA Link, Inc, Seoul, South Korea.
Jang HY; DNA Link, Inc, Seoul, South Korea.
Lee S; DNA Link, Inc, Seoul, South Korea.
Kang JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Choi YA; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee S; Ewha Research Center for Systems Biology (ERCSB) and Department of Life Science, Ewha Womans University, Seoul, South Korea.
Lee J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. .
Choi Y; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. .
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. .
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2020 Aug 06; Vol. 18 (1), pp. 307. Date of Electronic Publication: 2020 Aug 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*
Carcinoma, Squamous Cell*/genetics
Lung Neoplasms*/genetics
Animals ; Humans ; Lung ; Mice ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer.
Autorzy:
Shin S; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Jung JJ; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Im Y; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Shin SH; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kang D; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee G; Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, Republic of Korea.
Cho J; Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul, Republic of Korea.
Lee HY; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Park HY; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2020 Jan 10; Vol. 21 (1), pp. 13. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*therapy
Chemoradiotherapy/*methods
Lung Neoplasms/*therapy
Neoadjuvant Therapy/*methods
Postoperative Complications/*therapy
Pulmonary Diffusing Capacity/*methods
Aged ; Carcinoma, Non-Small-Cell Lung/physiopathology ; Chemoradiotherapy/trends ; Cohort Studies ; Female ; Humans ; Lung Neoplasms/physiopathology ; Male ; Middle Aged ; Neoadjuvant Therapy/trends ; Neoplasm Staging/methods ; Postoperative Complications/etiology ; Pulmonary Diffusing Capacity/drug effects ; Pulmonary Diffusing Capacity/physiology ; Respiratory Function Tests/methods ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer.
Autorzy:
Im Y; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Park HY; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Shin S; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Shin SH; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Lee H; Division of Pulmonary Medicine and Allergy, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, South Korea.
Ahn JH; Statistics and Data Center, Samsung Medical Center, Seoul, South Korea.
Sohn I; Statistics and Data Center, Samsung Medical Center, Seoul, South Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Lee HY; Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea. .; Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea. .
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2019 Jul 04; Vol. 20 (1), pp. 136. Date of Electronic Publication: 2019 Jul 04.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*epidemiology
Carcinoma, Non-Small-Cell Lung/*surgery
Lung Neoplasms/*epidemiology
Lung Neoplasms/*surgery
Postoperative Complications/*epidemiology
Aged ; Carcinoma, Non-Small-Cell Lung/diagnosis ; Cohort Studies ; Female ; Humans ; Lung Diseases/diagnosis ; Lung Diseases/epidemiology ; Lung Diseases/etiology ; Lung Neoplasms/diagnosis ; Male ; Neoplasm Staging/methods ; Postoperative Complications/diagnosis ; Postoperative Complications/etiology ; Prevalence ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-mutated Non-small Cell Lung Cancer.
Autorzy:
Lee J; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shim JH; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.; Department of Health Science and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
Park WY; Samsung Genome Institute, Samsung Medical Center, Seoul, Korea.; Department of Health Science and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.; Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim HK; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Sun JM; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Park K; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2019 Jan; Vol. 51 (1), pp. 408-412. Date of Electronic Publication: 2018 May 23.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Mutation*
Carcinoma, Non-Small-Cell Lung/*genetics
Lung Neoplasms/*genetics
Acrylamides ; Aniline Compounds ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Drug Resistance, Neoplasm ; ErbB Receptors/genetics ; Female ; Gene Frequency ; Humans ; Lung Neoplasms/drug therapy ; Middle Aged ; Piperazines/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Republic of Korea
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Genome-wide analysis of DNA methylation in bronchial washings.
Autorzy:
Um SW; 1Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710 South Korea.
Kim Y; Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 440-746 South Korea.
Lee BB; Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 440-746 South Korea.
Kim D; Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 440-746 South Korea.
Lee KJ; 1Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710 South Korea.
Kim HK; 3Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710 South Korea.
Han J; 4Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710 South Korea.
Kim H; 1Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710 South Korea.
Shim YM; 3Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 135-710 South Korea.
Kim DH; Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, 440-746 South Korea.; Samsung Medical Center, Research Institute for Future Medicine, #50 Ilwon-dong, Kangnam-gu, Professor Rm #5, Seoul, 135-710 South Korea.
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2018 May 18; Vol. 10, pp. 65. Date of Electronic Publication: 2018 May 18 (Print Publication: 2018).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Bronchoalveolar Lavage Fluid/*chemistry
Carcinoma, Non-Small-Cell Lung/*diagnosis
Genome-Wide Association Study/*methods
Lung Neoplasms/*diagnosis
Carcinoma, Non-Small-Cell Lung/genetics ; Case-Control Studies ; CpG Islands ; Epigenesis, Genetic ; Female ; Humans ; Logistic Models ; Lung Neoplasms/genetics ; Male ; Promoter Regions, Genetic ; Sensitivity and Specificity ; Smoking/adverse effects ; Smoking/genetics ; Smoking Cessation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term survival in locally advanced non-small cell lung cancer invading the great vessels and heart.
Autorzy:
Park B; Department of Thoracic and Cardiovascular Surgery, Chung-Ang University Hospital, Seoul, South Korea.
Cho JH; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2018 May; Vol. 9 (5), pp. 598-605. Date of Electronic Publication: 2018 Mar 30.
Typ publikacji:
Journal Article
MeSH Terms:
Blood Vessels/*physiopathology
Carcinoma, Non-Small-Cell Lung/*surgery
Heart/*physiopathology
Pericardium/*pathology
Aged ; Carcinoma, Non-Small-Cell Lung/epidemiology ; Carcinoma, Non-Small-Cell Lung/physiopathology ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness/physiopathology ; Neoplasm Staging ; Neoplasms, Second Primary ; Vascular Surgical Procedures
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience.
Autorzy:
Park H; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Oh D; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn YC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pyo H; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Noh JM; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Sun JM; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn JS; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn MJ; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Park K; Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2017 Oct; Vol. 49 (4), pp. 880-889. Date of Electronic Publication: 2016 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biopsy ; Carcinoma, Non-Small-Cell Lung/diagnosis ; Carcinoma, Non-Small-Cell Lung/mortality ; Chemoradiotherapy/adverse effects ; Chemoradiotherapy/methods ; Chemotherapy, Adjuvant/adverse effects ; Chemotherapy, Adjuvant/methods ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/diagnosis ; Lung Neoplasms/mortality ; Male ; Medication Adherence ; Middle Aged ; Multimodal Imaging ; Neoplasm Staging ; Prognosis ; Radiotherapy, Adjuvant/adverse effects ; Radiotherapy, Adjuvant/methods ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Inhibitory effect of traditional oriental medicine-derived monoamine oxidase B inhibitor on radioresistance of non-small cell lung cancer.
Autorzy:
Son B; Department of Integrated Biological Science, Pusan National University, Busan, Republic of Korea.
Jun SY; Department of Chemistry, Washington State University, Pullman, Washington, USA.
Seo H; Department of Integrated Biological Science, Pusan National University, Busan, Republic of Korea.
Youn H; Nuclear Science Research Institute, Pusan National University, Busan, Republic of Korea.
Yang HJ; Department of Biological Sciences, Pusan National University, Busan, Republic of Korea.
Kim W; Nuclear Science Research Institute, Pusan National University, Busan, Republic of Korea.; Department of Biological Sciences, Pusan National University, Busan, Republic of Korea.
Kim HK; Department of Nanomaterial Engineering and Nanoconvergence Technology, Pusan National University, Miryang, Republic of Korea.
Kang C; Department of Chemistry, Washington State University, Pullman, Washington, USA.
Youn B; Department of Integrated Biological Science, Pusan National University, Busan, Republic of Korea.; Department of Chemistry, Washington State University, Pullman, Washington, USA.; Nuclear Science Research Institute, Pusan National University, Busan, Republic of Korea.; Department of Biological Sciences, Pusan National University, Busan, Republic of Korea.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2016 Feb 24; Vol. 6, pp. 21986. Date of Electronic Publication: 2016 Feb 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents, Phytogenic/*pharmacology
Carcinoma, Non-Small-Cell Lung/*therapy
Lactates/*pharmacology
Lung Neoplasms/*therapy
Monoamine Oxidase/*genetics
Monoamine Oxidase Inhibitors/*pharmacology
Radiation Tolerance/*drug effects
Animals ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/metabolism ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Drugs, Chinese Herbal ; Epithelial-Mesenchymal Transition/drug effects ; Epithelial-Mesenchymal Transition/radiation effects ; Gamma Rays/therapeutic use ; Gene Expression Regulation, Neoplastic ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Medicine, East Asian Traditional ; Mice ; Mice, Nude ; Monoamine Oxidase/metabolism ; NF-kappa B/genetics ; NF-kappa B/metabolism ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A retrospective comparative analysis of elderly and younger patients undergoing pulmonary resection for stage I non-small cell lung cancer.
Autorzy:
Park B; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Lee G; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Kim HK; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Choi YS; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Zo JI; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Shim YM; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea.
Kim J; Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul, 135-710, South Korea. .
Pokaż więcej
Źródło:
World journal of surgical oncology [World J Surg Oncol] 2016 Jan 19; Vol. 14 (1), pp. 13. Date of Electronic Publication: 2016 Jan 19.
Typ publikacji:
Comparative Study; Journal Article; Observational Study
MeSH Terms:
Pneumonectomy*
Adenocarcinoma/*surgery
Carcinoma, Non-Small-Cell Lung/*surgery
Carcinoma, Squamous Cell/*surgery
Lung Neoplasms/*surgery
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Squamous Cell/mortality ; Carcinoma, Squamous Cell/pathology ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Highly sensitive and selective anticancer effect by conjugated HA-cisplatin in non-small cell lung cancer overexpressed with CD44.
Autorzy:
Quan YH; 1Department of Thoracic and Cardiovascular Surgery, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Kim B
Park JH
Choi Y
Choi YH
Kim HK
Pokaż więcej
Źródło:
Experimental lung research [Exp Lung Res] 2014 Dec; Vol. 40 (10), pp. 475-84. Date of Electronic Publication: 2014 Oct 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents/*pharmacology
Apoptosis/*drug effects
Carcinoma, Non-Small-Cell Lung/*pathology
Cisplatin/*pharmacology
Hyaluronan Receptors/*metabolism
Hyaluronic Acid/*pharmacology
Lung Neoplasms/*pathology
Up-Regulation/*physiology
Adenocarcinoma/metabolism ; Adenocarcinoma/pathology ; Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/pharmacology ; Carcinoma, Non-Small-Cell Lung/metabolism ; Cell Line ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Humans ; Hyaluronan Receptors/immunology ; Lung/drug effects ; Lung/metabolism ; Lung/pathology ; Lung Neoplasms/metabolism ; Neoplasm Invasiveness/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 22

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies